BMO Capital Maintains Market Perform on Medpace Holdings, Lowers Price Target to $400
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and lowers the price target from $460 to $400.
BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and lowers the price target from $460 to $400.